Health

Results: 5353-5364 of 5629

AstraZeneca Awards Funding to Eight Innovative Research Projects From Early-Career Scientists Around the World in Second R&D Postdoctoral Challenge

STEMCELL Technologies, Canada’s largest biotechnology company, is releasing its first annual sustainability report. The report, entitled Toward Sustainable Science, provides a comprehensive look at STEMCELL’s environmental, social, and governance performance over the company’s 2023 Fiscal Year (July 1, 2022 through June 30, 2023). (Photo: Business Wire)

STEMCELL Technologies Releases “Toward Sustainable Science” Report

Update on ConfIdeS Phase 3 trial of imlifidase in highly sensitized kidney transplant patients

Care Access mobile research vehicle at Martha's Vineyard clinic. (Photo: Business Wire)

FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial

New Long-Term Data from Incyte Phase 3 TRuE-V Program Demonstrates Efficacy of Continued Treatment with Opzelura® (Ruxolitinib) Cream in Nonsegmental Vitiligo Patients

Galderma @ EADV 2023: Phase III Trials Demonstrate Nemolizumab’s Efficacy and Rapid Onset of Action in Atopic Dermatitis and Prurigo Nodularis

Alfasigma S.p.A. Tender Offer for Intercept Pharmaceuticals, Inc. Commences

Incyte Announces Positive 52-Week Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental Vitiligo

Illustrative example: cancer associated fibroblasts (CAFs) and the tumor microenvironment. (Photo: Business Wire)

SOFIE and GE HealthCare Enter Licensing Agreement to Develop FAP PET Radiotracers

Cellares Announces Expanded Agreement with Bristol Myers Squibb to Include Second CAR-T Program in Cellares’ Technology Adoption Partnership Program

Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress

PR Newswire associated0

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition